Listed as Free on Udemy when checked on 3 November 2026. No coupon or subscription trial is required for the listed lessons. Enrollment needs a Udemy account; availability can change.
About this course
Estimating how a disease may develop is different from identifying the disease itself. AI can add another source of information to that discussion, but a model's output still needs interpretation, an appropriate setting and an understanding of uncertainty. Learning that distinction is a useful starting point before reading strong claims about predictive healthcare.
Anil Kumar Kalicharan's AI In Medical Prognosis introduces definitions, clinical-workflow examples, sample models, possible applications and limitations. Eight lectures total approximately eighty-four minutes, including a ten-minute coding-samples supplement. The page shows a January 2025 update. Although the description welcomes beginners, the requirements mention basic AI and healthcare concepts; some familiarity with that vocabulary would help a learner follow the discussion.
| Official course | AI In Medical Prognosis |
|---|---|
| Created by | Anil Kumar Kalicharan |
| Platform | Udemy |
| Language | English |
| Level | Beginner — Intermediate on Udemy |
| Listed duration | 84 minutes; 8 lectures across 8 sections |
| Certificate | Not included with a new free enrollment |
What you’ll learn
Explore how prognostic questions connect information, models and clinical workflows. Consider what a risk estimate represents, how uncertainty should remain visible, and why data quality, bias, explainability and oversight matter. Use the material as an introduction to evaluating descriptions of medical AI, rather than as a qualification to predict an individual's outcome or deploy a clinical system.
Skills you’ll gain
- Prognostic-question framing
- Risk-estimate interpretation
- Clinical-workflow awareness
- Data-quality questioning
- Model-limitation review
- Human-AI evaluation context
Keep uncertainty inside the definition
The definition lesson distinguishes prognosis from diagnosis and discusses communicating possible outcomes. The National Cancer Institute describes prognosis as an estimate of a disease's likely course or outcome. Its cancer information explains why statistics from groups cannot predict exactly what will happen to an individual. A useful learning habit is therefore to ask what population, time period and outcome an estimate concerns, rather than treating a probability as a personal certainty.
That boundary also matters when AI is involved. A sophisticated interface or a numerical score does not remove uncertainty. The course is not a source of individual survival predictions, and this article does not interpret symptoms, scans or test results. Personal questions about prognosis belong with an appropriately qualified care team that can consider the actual clinical circumstances and explain what available evidence means.
Read the workflow around the model
The process lesson uses a cancer-care setting involving imaging, pathology, a multidisciplinary discussion and communication with a patient. It places a model inside a wider flow of information and professional work. That is different from assuming a standalone prediction automatically tells someone what to do. When studying the example, distinguish the information entering a discussion from the responsibility for interpreting it and deciding how it may be used.
The sample-framework and use-case lessons extend the discussion to risk scores and healthcare information systems, including examples related to sepsis and cardiovascular conditions. Their presence in the syllabus does not establish that all such tools work equally well, suit the same population or have the same regulatory status. The article adopts no treatment threshold, intervention rule or claim that an unnamed model is suitable for clinical use.
Evaluate examples and technical claims
A short examples lecture names institutions and tools and describes systems as being in production. Those descriptions have not been independently validated here as current deployments or evidence of patient benefit. A case mentioned in a recording is a starting point for further source checking. Current FDA transparency principles for machine-learning medical devices emphasise clear intended use, relevant information and the context in which users interpret outputs, including the performance of the human-AI team.
The coding supplement introduces topics such as cleaning data, logistic regression, XGBoost, explainability and bias. A ten-minute supplement is not a complete clinical model-development and validation programme. The course page's broader hands-on wording should not be read as proof that a learner has trained, tested or deployed a safe system. No sample code, repository, dataset or interface has been executed or certified by this article.
Treat limitations as part of the subject
The dedicated benefits-and-limitations lesson covers data quality, bias, integration, explainability and human oversight. Those issues belong in the evaluation itself. FDA good-machine-learning-practice principles also distinguish clinically relevant testing from training data and address ongoing monitoring. Understanding a model's explanation is not the same as establishing its accuracy, usefulness or safety in a different setting. The recording does not replace the evidence needed for a particular intended use.
For optional private reflection, imagine a fictional risk-score dashboard and identify its intended user, predicted outcome and one important uncertainty. This is an illustrative learning prompt, not a request to assess a real patient. The recorded course is free to view; clinical services, professional advice and implementation have separate requirements. No patient information is uploaded, no model is run and no care decision is made. Completion provides introductory learning, with no professional accreditation, clinical permission or guaranteed improvement in outcomes.
National Cancer Institute: prognosis: Read the cancer-specific explanation of prognosis and the limits of group statistics. FDA: transparency principles: Review the primary discussion of intended use, user information and human-AI performance. FDA: good machine learning practice principles: Consult the official principles on clinically relevant testing and monitoring; no file is reproduced here.
Related courses for your next step
- Compare another approachFree Safeguarding Procedures Course
Focus: Frame administrative questions about safeguarding responsibilities. · Organise the purpose of policies and supporting documents.
Beginner
- Add a related skillFree Proposal Writing Course
Focus: Proposal message development · Customer need analysis
Beginner
Compare course focus, level and study time
| Course | Level | Focus | Study time |
|---|---|---|---|
| This course — Free Medical AI Prognosis Course: Understand Models, Workflows and Limits | Beginner | Prognostic-question framing · Risk-estimate interpretation · Clinical-workflow awareness | 84 minutes (Udemy listing) |
| Free Safeguarding Procedures Course: Explore Administrative Policies, Records and Review | Beginner | Frame administrative questions about safeguarding responsibilities. · Organise the purpose of policies and supporting documents. · Recognise registration as part of a wider service process. | 34 minutes (Udemy listing) |
| Free Proposal Writing Course: Build Clear Win Themes with Supporting Proof | Beginner | Proposal message development · Customer need analysis · Benefit articulation | 71 minutes (Udemy listing) |
Frequently asked questions
Can I use the course to predict my own or another person's outcome?
No. It is an educational introduction, not a personal prognosis service. Individual clinical questions require an appropriately qualified care team.
Does the coding supplement qualify a clinical model for use?
No. A short example does not establish validation, regulatory status, clinical safety or suitability for a particular intended use.
Do I need to upload patient records to study?
No such action is required by this article. Use fictional examples, and keep actual health information within authorised professional processes.
Questions & discussion
Share a useful question or correction. Comments appear after moderation. Please avoid personal or sensitive information.